Here’s what VC-backed biotechs should focus on amid covid-19

Tom Walker of Rev1 Ventures addresses the question of whether investors should back biotech start-ups that focus on the coronavirus and other potential pandemics. Here's what you should know.

DealsCoronavirusHealthcareOpinionGuest Opinions